Daniel Loeb's position in Ventyx Biosciences is currently worth $57.7 Million. That's 1.0% of their equity portfolio (28th largest holding). The investor owns 8.48% of the outstanding Ventyx Biosciences stock. The investor's estimated purchase price is $81.7 Million, resulting in a loss of 29%.